endocyte inc (ECYT:NASDAQ GS)

Last $14.02 USD

Change Today 0.00 / 0.00%

Volume 137.6K

ECYT On Other Exchanges

Symbol

Exchange

ECYT:US

NASDAQ GS

9EY:GR

Berlin

As of 8:10 PM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements Ratios Pensions & Options SEC Filings

Financial Statements for endocyte inc (ECYT)

Year over year, Endocyte, Inc. has been able to grow revenues from $191.0K USD to $34.7M USD. Most impressively, the company has been able to reduce the percentage of sales devoted to selling, general and administrative costs from 5,234.97% to 43.41%. This was a driver that led to an improvement in the bottom line from a loss of $40.5M USD to a smaller loss of $17.3M USD.

Income Statement Balance Sheet Cash Flow

Currency in Millions of US Dollars	As of:	Dec 31 2009	Dec 31 2010	Dec 31 2011	Dec 31 2012	4 Year Trend
Revenues		3.0	--	0.2	34.7
TOTAL REVENUES		3.0	--	0.2	34.7
GROSS PROFIT		3.0	--	0.2	34.7
Selling General & Admin Expenses, Total		3.9	6.0	10.0	15.1
R&D Expenses		14.8	14.6	28.5	35.7
OTHER OPERATING EXPENSES, TOTAL		18.7	20.6	38.5	50.7
OPERATING INCOME		-15.7	-20.6	-38.3	-16.0
Interest Expense		-1.4	-1.1	-2.0	-0.6
Interest and Investment Income		0.0	0.0	0.1	0.3
NET INTEREST EXPENSE		-1.4	-1.1	-1.9	-0.3
Other Non-Operating Income (Expenses)		0.1	1.7	0.0	0.1
EBT, EXCLUDING UNUSUAL ITEMS		-17.0	-19.9	-40.2	-16.3
Gain (Loss) on Sale of Assets		0.0	--	0.0	0.0
Other Unusual Items, Total		--	-0.1	-0.3	-1.0
Other Unusual Items		--	-0.1	-0.3	-1.0
EBT, INCLUDING UNUSUAL ITEMS		-17.0	-20.1	-40.5	-17.3
Earnings from Continuing Operations		-17.0	-20.1	-40.5	-17.3
NET INCOME		-17.0	-20.1	-40.5	-17.3
NET INCOME TO COMMON INCLUDING EXTRA ITEMS		-17.0	-20.1	-40.5	-17.3
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS		-17.0	-20.1	-40.5	-17.3